DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Visken (Pindolol) - Published Studies


Visken Related Published Studies

Well-designed clinical trials related to Visken (Pindolol)

Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression. [2011.07]

Pindolol augmentation enhances response outcomes in first depressive episodes. [2009.07]

Glomerular filtration rate after tramadol, parecoxib and pindolol following anaesthesia and analgesia in comparison with morphine in dogs. [2009.01]

Paroxetine with pindolol augmentation: A double-blind, randomized, placebo-controlled study in depressed in-patients. [2008.02]

Noradrenergic activity is associated with response to pindolol in aggressive Alzheimer's disease patients. [2004.06]

Pindolol does not augment cortisol and prolactin responses to paroxetine in healthy subjects. [2004.05]

Once-daily high-dose pindolol for SSRI-refractory depression. [2004.02.15]

Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial. [2004.02]

Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency. [2003.12]

Effect of pindolol and milnacipran versus milnacipran and placebo on plasma prolactin and adrenocorticotrophic hormone in depressed subjects. [2003.10]

EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans. [2003.03]

Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers. [2003.03]

Influence of antihypertensive treatment with perindopril, pindolol or felodipinon plasma leptin concentration in patients with essential hypertension. [2002.11]

Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study. [2001.10]

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression. [2001.09.01]

Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol. [2001.06]

Pindolol augmentation in aggressive schizophrenic patients: a double-blind crossover randomized study. [2001.03]

Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors. [2001.02]

Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial. [2000.10]

Does the addition of pindolol accelerate the response to electroconvulsive therapy in patients with major depression? A double-blind, placebo-controlled pilot study. [2000.06]

Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial. [2000.03]

Bioequivalence of two oral immediate release formulations of pindolol in healthy volunteers assessed by ratio analysis. [2000]

The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial. [1999.05.01]

Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance. [1999.04]

A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius. [1999.04]

Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression. A placebo-controlled trial. [1999.04]

Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study. [1998.12]

Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Reseau de Recherche et d'Experimentation Psychopharmacologique. [1998.10]

Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study. [1998.09]

Personality correlates of +/- pindolol induced decreases in prolactin. [1998.01]

Comparison of chlorthalidone, propranolol and bopindolol in six-month treatment of arterial hypertension. [1998]

How long should pindolol be associated with paroxetine to improve the antidepressant response? [1997.12]

Pindolol augmentation of treatment-resistant depressed patients. [1997.10]

Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol. [1997.07]

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. [1997.05.31]

Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency. [1997.03]

Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial. [1997.01]

Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression. [1996.12.16]

Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects. [1996.07]

Effect of pindolol on hormone secretion and body temperature: partial agonist effects. [1996]

Uterine and fetal hemodynamics and fetal cardiac function after atenolol and pindolol infusion. A randomized study. [1995.10]

Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men. [1995.09.29]

Effect of pindolol pretreatment on MK-212-induced plasma cortisol and prolactin responses in normal men. [1995.09.01]

Effect of pindolol on the prolactin response to d-fenfluramine. [1995.04]

Effect of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man. [1994.05]

Extent of beta 1- and beta 2-receptor occupancy in plasma assesses the antagonist activity of metoprolol, pindolol, and propranolol in the elderly. [1993.12]

Effects of propranolol and pindolol on cardiac output during extended periods of low-intensity physical activity. [1993.11.15]

Blood pressure reactivity in the evaluation of resting blood pressure and mood responses to pindolol and propranolol in hypertensive patients. [1993.09]

Comparison of effects of propranolol versus pindolol on sinus rate and pacing frequency in sick sinus syndrome. [1993.01.01]

Noninvasive estimates of the inodilatory effects of isoprenaline and their inhibition by transdermally delivered mepindolol in healthy men. [1992.09]

Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients. [1992.08]

A comparative study of nicardipine and pindolol as second-line treatments in essential hypertension. [1992.06]

Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics. [1992.04.11]

Flow velocity analysis of umbilical and uterine artery flow in pre-eclampsia treated with propranolol or pindolol. [1992.02]

Acute changes in forearm haemodynamics produced by cigarette smoking in healthy normotensive non-smokers are not influenced by propranolol or pindolol. [1992]

Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers. [1992]

Bopindolol in chronic stable angina pectoris: duration and extent of antianginal action. [1991.12]

Transdermal monotherapy with mepindolol BIO TSD in patients with stable angina pectoris. Placebo-controlled, crossover investigation of a new therapeutic concept with 12-hours overnight application. [1991.11]

Effects of pindolol on the cardiovascular response to tracheal intubation. [1991.10]

Stroke volume during submaximal exercise in endurance-trained normotensive subjects and in untrained hypertensive subjects with beta blockade (propranolol and pindolol). [1991.02.15]

Monotherapy of stable angina pectoris with bopindolol in comparison with diltiazem. [1991]

Changes in plasma free fatty acids and glycerols during prolonged exercise in trained and hypertensive persons taking propranolol and pindolol. [1990.12.01]

Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects. [1990.11]

Comparison of the antihypertensive efficiency of nitrendipine, metoprolol, mepindolol and enalapril using ambulatory 24-hour blood pressure monitoring. [1990.10.15]

Withdrawal phenomena after atenolol and bopindolol: haemodynamic responses in healthy volunteers. [1990.10]

Effect of metoprolol and pindolol monotherapy on plasma lipid- and lipoprotein-cholesterol levels (including the HDL subclasses) in mild hypertensive males and females. [1990.06]

[The local anesthetic effect and subjective tolerance of 0.5% befunolol and 1% pindolol in healthy eyes] [1990.04]

Effect of propranolol and pindolol on the up-regulation of lymphocytic beta adrenoceptors during acute submaximal physical exercise. A placebo-controlled double-blind study. [1990.04]

Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol. [1990.02]

Haemodynamic effects of bopindolol and atenolol in coronary artery disease. A noninvasive study. [1990]

[Comparison of the antihypertensive effects of bopindolol and metoprolol in the treatment of arterial hypertension] [1990]

Comparison of bopindolol and atenolol in chronic stable angina pectoris. [1990]

Transdermal delivery of mepindolol and propranolol in normal man. 1st communication: study design, clinical and pharmacodynamic aspects. [1989.11]

Effects of pindolol and propranolol on blood lipids in hypertensive patients. [1989.10]

Improved blood pressure control with isradipine in hypertensive patients treated with pindolol. [1989.04.17]

[Beta receptor block versus calcium antagonism. A comparative study of bopindolol and nifedipine with special regard to quality of life] [1989.04]

Improved control of atrial fibrillation with combined pindolol and digoxin therapy. [1989.01]

Improvement in wall motion after pindolol: a mechanism for the preservation of left ventricular function in coronary artery disease. [1989]

Effects of atenolol and pindolol on the hypokalaemic and cardiovascular responses to adrenaline infusion. [1989]

Bopindolol and atenolol in patients with stable angina pectoris. Double-blind randomized comparative trial. [1989]

Acute hemodynamic effects of pindolol and propranolol in patients with dilated cardiomyopathy: relevance of intrinsic sympathomimetic activity. [1988.11]

Comparison of the effects of pindolol and atenolol on hemodynamic function in systemic hypertension. [1988.09.01]

[Ergometric evaluation of the cardioprotective effect of pindolol in coronary disease. Comparison of 2 galenic forms] [1988.07.02]

No effect of Pindolol on postural hypotension in type 1 (insulin-dependent) diabetic patients with autonomic neuropathy. A randomised double-blind controlled study. [1988.05]

Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients. [1988.01]

[Comparative effects of pindolol and atenolol on blood pressure and lipids in mild to moderate arterial hypertension] [1988]

Bopindolol in the treatment of moderate hypertension: a dose-response study. [1988]

Haemodynamic effects of atenolol and bopindolol at rest and during isometric exercise. A non-invasive study in healthy volunteers. [1988]

Comparison of the acute haemodynamic effects of bopindolol and propranolol at rest and during supine exercise. [1988]

The long-term effect of isradipine in pindolol-treated patients. [1987.12]

An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man. [1987.11]

Antihypertensive and hormonal responses to beta-blockade with intrinsic sympathomimetic activity: pindolol versus epanolol. [1987.11]

[Changes in lung function following administration of eyedrops containing timolol, metipranolol, pindolol and pilocarpine in healthy probands and patients with mild bronchial asthma] [1987.10.01]

[Pindolol in intraoperatively developing isorhythmic AV dissociation] [1987.08]

Addition of the calcium antagonist PN 200-110 to pindolol markedly augments the antihypertensive effect in essential hypertension. [1987]

Vasodilatory effects of carvedilol and pindolol. [1987]

Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol. [1987]

Influence of pindolol and timolol treatment on the visual fields of glaucoma patients. [1986.09]

Well-designed clinical trials possibly related to Visken (Pindolol)

Preclinical and clinical characterization of the selective serotonin-1A receptor antagonist DU-125530 for antidepressant treatment. [2011.11.03]

If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies. [2011.01.01]

A short duration of untreated illness (DUI) improves response outcomes in first-depressive episodes. [2010.01]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017